Systematic computational strategies for identifying protein targets and lead discovery

被引:1
|
作者
Kataria, Arti [1 ]
Srivastava, Ankit [2 ]
Singh, Desh Deepak [3 ]
Haque, Shafiul [4 ]
Han, Ihn [5 ]
Yadav, Dharmendra Kumar [6 ]
机构
[1] NIAID, Natl Inst Hlth NIH, Lab Bacteriol, NIH, Hamilton, MT 59840 USA
[2] NIAID, Natl Inst Hlth NIH, Lab Neurol Infect & Immun, NIH, Hamilton, MT 59840 USA
[3] Amity Univ Rajasthan, Amity Inst Biotechnol, Jaipur, India
[4] Jazan Univ, Coll Nursing & Hlth Sci, Res & Sci Studies Unit, Jazan 45142, Saudi Arabia
[5] Kwangwoon Univ, Plasma Biosci Res Ctr, Appl Plasma Med Ctr, Dept Elect & Biol Phys, Seoul 01897, South Korea
[6] Gachon Univ, Coll Pharm, Dept Biol, Hambakmoeiro 191, Incheon 21924, South Korea
来源
RSC MEDICINAL CHEMISTRY | 2024年 / 15卷 / 07期
关键词
X-RAY CRYSTALLOGRAPHY; LIGAND-BINDING SITES; DRUG DISCOVERY; MOLECULAR-DYNAMICS; CONNECTIVITY MAP; L-ASPARAGINASE; EXPRESSION SIGNATURES; STRUCTURE PREDICTION; STRUCTURAL BIOLOGY; SCORING FUNCTION;
D O I
10.1039/d4md00223g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Computational algorithms and tools have retrenched the drug discovery and development timeline. The applicability of computational approaches has gained immense relevance owing to the dramatic surge in the structural information of biomacromolecules and their heteromolecular complexes. Computational methods are now extensively used in identifying new protein targets, druggability assessment, pharmacophore mapping, molecular docking, the virtual screening of lead molecules, bioactivity prediction, molecular dynamics of protein-ligand complexes, affinity prediction, and for designing better ligands. Herein, we provide an overview of salient components of recently reported computational drug-discovery workflows that includes algorithms, tools, and databases for protein target identification and optimized ligand selection. Computational algorithms and tools have retrenched the drug discovery and development timeline.
引用
收藏
页码:2254 / 2269
页数:16
相关论文
共 50 条
  • [21] IDENTIFYING TARGETS FOR THE TREATMENT OF DYSTONIA AND PRECLINICALTESTING OF THE LEAD COMPOUNDS
    Balcioglu, Ayguel
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 38 (01) : 53 - 54
  • [22] Protein Interfaces as Targets in Drug Discovery
    Fattorusso, Caterina
    Persico, Marco
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2015, 15 (20) : 2003 - 2004
  • [23] Genomic targets and structure-based lead discovery
    Zamudio, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 231 - COMP
  • [24] Computational strategies for design and discovery of nanostructured thermoelectrics
    Hao, Shiqiang
    Dravid, Vinayak P.
    Kanatzidis, Mercouri G.
    Wolverton, Christopher
    NPJ COMPUTATIONAL MATERIALS, 2019, 5 (1)
  • [25] Identifying protein interactions - Computational approaches
    Appella, E
    Anderson, CW
    FEBS JOURNAL, 2005, 272 (20) : 5099 - 5100
  • [26] Computational strategies for design and discovery of nanostructured thermoelectrics
    Shiqiang Hao
    Vinayak P. Dravid
    Mercouri G. Kanatzidis
    Christopher Wolverton
    npj Computational Materials, 5
  • [27] Therapeutic Monoclonal Antibodies to Complex Membrane Protein Targets: Antigen Generation and Antibody Discovery Strategies
    Roger B. Dodd
    Trevor Wilkinson
    Darren J. Schofield
    BioDrugs, 2018, 32 : 339 - 355
  • [28] Innovative lead discovery strategies for tropical diseases
    Nwaka, Solomon
    Hudson, Alan
    NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (11) : 941 - 955
  • [29] Therapeutic Monoclonal Antibodies to Complex Membrane Protein Targets: Antigen Generation and Antibody Discovery Strategies
    Dodd, Roger B.
    Wilkinson, Trevor
    Schofield, Darren J.
    BIODRUGS, 2018, 32 (04) : 339 - 355
  • [30] Innovative lead discovery strategies for tropical diseases
    Solomon Nwaka
    Alan Hudson
    Nature Reviews Drug Discovery, 2006, 5 : 941 - 955